Inoviem品牌介绍
品牌简介
Inoviem是一家生物分析合同研究组织(CRO)，使药物开发人员能够更精确地了解化合物的临床作用模式(MoA)，从而使候选药物能够迅速进入临床试验。基于其开创性的NPOT®和PIMS®无标签技术，Inoviem在药物靶标相互作用分析方面有深入研究。这是世界上第一个在生理环境中(即直接在未经修饰的人体组织上)破译天然临床药物蛋白质和核酸的无标签技术。这一成就使Inoviem成为一种方法的领导者，为客户提供了识别药物治疗效果的新方法。
Inoviem,
a bioanalytical Contract Research Organization (CRO), enables drug developers
to gain higher precision in the understanding of a compound’s clinical Mode of
Action (MoA), so that a drug candidate can move rapidly to clinical trials. Inoviem’s expertise in drug-target
interaction analysis is based on its groundbreaking NPOT® and PIMS® label-free
technologies. These are the world’s
first label-free technologies to decipher the native clinical agent’s proteins
and nucleic acids within a physiological environment i.e. directly on
non-modified human tissue. This
achievement distinguishes Inoviem as a leader in an approach that offers
clients new dimensions in identifying the therapeutic effect of pharmacological
agents.
Main product
Label-Free Technologies-unNPOT®
and PIMS®
https://www.inoviem.com/
